Safety Study of AG-120 or AG-221 in Combination With Induction and Consolidation Therapy in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) With an IDH1 and/or IDH2 Mutation

Clinical trial NCT02632708 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02632708
Sponsor: Institut de Recherches Internationales Servier
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Newly Diagnosed Acute Myeloid Leukemia (AML)Untreated AML AML Arising From Myelodysplastic Syndrome (MDS)AML Arising From Antecedent Hematologic Disorder (AHD)AML Arising After Exposure to Genotoxic Injury

Start date: 2015-12-31
Primary completion: 2018-12-13
Enrollment: 153

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.